|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 123.21 USD | -0.23% |
|
+5.94% | +88.60% |
| Dec. 12 | Jefferies Adjusts Tapestry Price Target to $142 From $135, Maintains Buy Rating | MT |
| Dec. 04 | CEOs see younger consumers driving growth amid tariffs, AI changes | RE |
| Fiscal Period: June | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 8.4 | 9.73 | 10.19 | 7.66 | 8.81 | |||||
Return on Total Capital | 10.16 | 12.43 | 13.18 | 9.11 | 10.72 | |||||
Return On Equity % | 30.14 | 30.89 | 41.02 | 31.54 | 9.76 | |||||
Return on Common Equity | 30.14 | 30.89 | 41.02 | 31.54 | 9.76 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 70.89 | 69.57 | 70.78 | 73.29 | 75.44 | |||||
SG&A Margin | 51.83 | 51.34 | 53.18 | 54.46 | 55.35 | |||||
EBITDA Margin % | 22.87 | 21.15 | 20.34 | 21.44 | 22.41 | |||||
EBITA Margin % | 19.06 | 18.23 | 17.6 | 18.93 | 20.16 | |||||
EBIT Margin % | 19.06 | 18.23 | 17.6 | 18.83 | 20.09 | |||||
Income From Continuing Operations Margin % | 14.52 | 12.81 | 14.05 | 12.23 | 2.61 | |||||
Net Income Margin % | 14.52 | 12.81 | 14.05 | 12.23 | 2.61 | |||||
Net Avail. For Common Margin % | 14.52 | 12.81 | 14.05 | 12.23 | 2.61 | |||||
Normalized Net Income Margin | 11.14 | 10.69 | 10.73 | 10.57 | 11.85 | |||||
Levered Free Cash Flow Margin | 18.09 | 10.33 | 8.67 | 13.89 | 12.15 | |||||
Unlevered Free Cash Flow Margin | 18.9 | 10.98 | 9.36 | 17.36 | 14.57 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.7 | 0.85 | 0.93 | 0.65 | 0.7 | |||||
Fixed Assets Turnover | 2.44 | 3.34 | 3.53 | 3.54 | 3.84 | |||||
Receivables Turnover (Average Receivables) | 29.21 | 29.54 | 28.72 | 30.34 | 29.99 | |||||
Inventory Turnover (Average Inventory) | 2.27 | 2.35 | 2.03 | 2.04 | 2.04 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 2.37 | 1.75 | 1.84 | 5.14 | 1.87 | |||||
Quick Ratio | 1.73 | 0.97 | 0.92 | 4.48 | 1.05 | |||||
Operating Cash Flow to Current Liabilities | 0.93 | 0.58 | 0.76 | 0.73 | 0.78 | |||||
Days Sales Outstanding (Average Receivables) | 12.7 | 12.32 | 12.67 | 12 | 12.14 | |||||
Days Outstanding Inventory (Average Inventory) | 163.23 | 154.7 | 178.98 | 178.18 | 178.16 | |||||
Average Days Payable Outstanding | 63.97 | 76.65 | 91.19 | 93.76 | 94.05 | |||||
Cash Conversion Cycle (Average Days) | 111.97 | 90.37 | 100.46 | 96.41 | 96.25 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 105.56 | 142.85 | 144.63 | 302.59 | 454.56 | |||||
Total Debt / Total Capital | 51.35 | 58.82 | 59.12 | 75.16 | 81.97 | |||||
LT Debt/Equity | 95.73 | 128.81 | 130.42 | 281.73 | 417.75 | |||||
Long-Term Debt / Total Capital | 46.57 | 53.04 | 53.31 | 69.98 | 75.33 | |||||
Total Liabilities / Total Assets | 61.12 | 68.54 | 67.99 | 78.38 | 86.96 | |||||
EBIT / Interest Expense | 14.78 | 17.58 | 16.04 | 3.4 | 5.19 | |||||
EBITDA / Interest Expense | 24.04 | 28.18 | 25.98 | 5.4 | 7.9 | |||||
(EBITDA - Capex) / Interest Expense | 22.47 | 26.82 | 23.46 | 5.11 | 7.45 | |||||
Total Debt / EBITDA | 1.93 | 1.67 | 1.73 | 4.39 | 1.82 | |||||
Net Debt / EBITDA | 0.8 | 1.18 | 1.34 | 0.78 | 1.3 | |||||
Total Debt / (EBITDA - Capex) | 2.07 | 1.76 | 1.92 | 4.64 | 1.93 | |||||
Net Debt / (EBITDA - Capex) | 0.86 | 1.24 | 1.49 | 0.83 | 1.38 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 15.82 | 16.33 | -0.35 | 0.15 | 5.09 | |||||
Gross Profit, 1 Yr. Growth % | 21.34 | 14.15 | 1.39 | 3.7 | 8.17 | |||||
EBITDA, 1 Yr. Growth % | 99.64 | 8.64 | -4.19 | 5.03 | 9.85 | |||||
EBITA, 1 Yr. Growth % | 167.21 | 12.54 | -3.79 | 6.47 | 11.93 | |||||
EBIT, 1 Yr. Growth % | 167.21 | 12.54 | -3.79 | 6.5 | 12.1 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -227.93 | 2.65 | 9.31 | -12.82 | -77.55 | |||||
Net Income, 1 Yr. Growth % | -227.93 | 2.65 | 9.31 | -12.82 | -77.55 | |||||
Normalized Net Income, 1 Yr. Growth % | 204.49 | 12.98 | -0.04 | -1.93 | 17.85 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -226.03 | 7.46 | 22.4 | -9.79 | -76.57 | |||||
Accounts Receivable, 1 Yr. Growth % | 3.57 | 26.02 | -16.17 | 7.9 | 4.86 | |||||
Inventory, 1 Yr. Growth % | -0.28 | 35.3 | -7.51 | -10.3 | 4.35 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -14.12 | -16.03 | 6.42 | -5.87 | -0.47 | |||||
Total Assets, 1 Yr. Growth % | 5.78 | -13.33 | -2.04 | 88.23 | -50.88 | |||||
Tangible Book Value, 1 Yr. Growth % | -245.66 | -154.81 | -3.97 | -209.49 | -349.14 | |||||
Common Equity, 1 Yr. Growth % | 43.18 | -29.88 | -0.34 | 27.18 | -70.39 | |||||
Cash From Operations, 1 Yr. Growth % | 225.23 | -35.54 | 14.3 | 28.75 | -3.11 | |||||
Capital Expenditures, 1 Yr. Growth % | -43.52 | -19.05 | 96.17 | -40.88 | 12.67 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 317.62 | -33.08 | -16.36 | 48.51 | -8.05 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 269.36 | -31.94 | -15.07 | 72.89 | -11.76 | |||||
Dividend Per Share, 1 Yr. Growth % | - | - | 20 | 16.67 | 0 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | -2.36 | 16.07 | 7.66 | -0.1 | 2.59 | |||||
Gross Profit, 2 Yr. CAGR % | 0.25 | 17.79 | 7.47 | 2.54 | 5.91 | |||||
EBITDA, 2 Yr. CAGR % | 9.9 | 96.49 | 3.02 | 2.14 | 7.7 | |||||
EBITA, 2 Yr. CAGR % | 15.6 | 221.49 | 5.29 | 3.63 | 9.8 | |||||
EBIT, 2 Yr. CAGR % | 15.6 | 221.49 | 5.29 | 3.37 | 9.6 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 13.87 | 14.59 | 5.93 | -2.38 | -55.76 | |||||
Net Income, 2 Yr. CAGR % | 13.87 | 14.59 | 5.93 | -2.38 | -55.76 | |||||
Normalized Net Income, 2 Yr. CAGR % | 15.64 | 406.92 | 7.62 | 1.24 | 7.85 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 15.54 | 16.38 | 14.68 | 5.08 | -54.03 | |||||
Accounts Receivable, 2 Yr. CAGR % | -18.05 | 14.25 | 2.78 | -4.9 | 6.37 | |||||
Inventory, 2 Yr. CAGR % | -2.83 | 16.15 | 11.86 | -8.92 | -3.25 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 52.2 | -15.08 | -5.47 | 0.08 | -3.21 | |||||
Total Assets, 2 Yr. CAGR % | 10.4 | -4.25 | -7.86 | 35.79 | -3.84 | |||||
Tangible Book Value, 2 Yr. CAGR % | 43.63 | -10.65 | -27.45 | 2.54 | 65.16 | |||||
Common Equity, 2 Yr. CAGR % | -3.68 | 0.2 | -16.4 | 12.58 | -38.63 | |||||
Cash From Operations, 2 Yr. CAGR % | 29.25 | 44.79 | -14.17 | 21.31 | 11.69 | |||||
Capital Expenditures, 2 Yr. CAGR % | -34.96 | -32.39 | 26.01 | 7.69 | -18.38 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 62.89 | 221.49 | -24.62 | 17.2 | 17.26 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 58.25 | 156.54 | -23.41 | 27.01 | 23.93 | |||||
Dividend Per Share, 2 Yr. CAGR % | - | -0.64 | - | 18.32 | 8.01 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | -0.76 | 3.51 | 10.32 | 5.1 | 1.6 | |||||
Gross Profit, 3 Yr. CAGR % | 0.91 | 4.68 | 12.05 | 6.2 | 4.38 | |||||
EBITDA, 3 Yr. CAGR % | 1.59 | 9.13 | 54.66 | 3.87 | 4.65 | |||||
EBITA, 3 Yr. CAGR % | 3.32 | 14.13 | 115.04 | 6.09 | 6.33 | |||||
EBIT, 3 Yr. CAGR % | 3.32 | 14.13 | 115.04 | 5.91 | 6.2 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 28.03 | 10 | 12.8 | -0.73 | -40.19 | |||||
Net Income, 3 Yr. CAGR % | 28.03 | 10 | 12.8 | -0.73 | -40.19 | |||||
Normalized Net Income, 3 Yr. CAGR % | 3.73 | 14.28 | 195.06 | 4.56 | 6.5 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 28.82 | 12.78 | 18.35 | 5.86 | -36.28 | |||||
Accounts Receivable, 3 Yr. CAGR % | -13.94 | -5.41 | 3.04 | 4.46 | -1.75 | |||||
Inventory, 3 Yr. CAGR % | 2.93 | 8.5 | 7.66 | 3.93 | -4.69 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 34.92 | 24.83 | -8.45 | -5.61 | -0.1 | |||||
Total Assets, 3 Yr. CAGR % | 7.87 | 1.85 | -3.52 | 16.92 | -3.25 | |||||
Tangible Book Value, 3 Yr. CAGR % | 177.99 | 4.18 | -8.48 | -16.78 | 37.85 | |||||
Common Equity, 3 Yr. CAGR % | 0.15 | -13.35 | 0.02 | -3.85 | -27.87 | |||||
Cash From Operations, 3 Yr. CAGR % | 9.89 | 2.49 | 33.81 | -1.75 | 12.56 | |||||
Capital Expenditures, 3 Yr. CAGR % | -24.3 | -30.04 | -3.57 | -2.08 | 9.33 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 26.09 | 20.79 | 105.23 | -3.03 | 8.09 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 23.79 | 19.16 | 77.47 | 2.91 | 12.49 | |||||
Dividend Per Share, 3 Yr. CAGR % | - | -9.52 | 5.81 | - | 11.87 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 5.05 | 8.29 | 2.53 | 2.05 | 7.16 | |||||
Gross Profit, 5 Yr. CAGR % | 5.94 | 8.56 | 3.53 | 3.82 | 9.55 | |||||
EBITDA, 5 Yr. CAGR % | 5.89 | 6.64 | 1.56 | 5.63 | 33.81 | |||||
EBITA, 5 Yr. CAGR % | 7.12 | 8.44 | 3.38 | 9.03 | 64.34 | |||||
EBIT, 5 Yr. CAGR % | 7.12 | 8.44 | 3.38 | 8.92 | 64.22 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 12.62 | 7.7 | 18.68 | 4.87 | -22.42 | |||||
Net Income, 5 Yr. CAGR % | 12.62 | 7.7 | 18.68 | 4.87 | -22.42 | |||||
Normalized Net Income, 5 Yr. CAGR % | 6.45 | 7.84 | 4.49 | 8.04 | 97.27 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 12.32 | 8.69 | 22.97 | 9.63 | -18.92 | |||||
Accounts Receivable, 5 Yr. CAGR % | -3.97 | -1.2 | -7.6 | -5.2 | 4.36 | |||||
Inventory, 5 Yr. CAGR % | 9.86 | 16.18 | 6.42 | 1.17 | 3.15 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 18.79 | 21.44 | 17.02 | 14.27 | -6.39 | |||||
Total Assets, 5 Yr. CAGR % | 11.37 | 4.49 | 1.28 | 14.26 | -3.65 | |||||
Tangible Book Value, 5 Yr. CAGR % | -20.33 | -31.76 | 62.43 | 3.52 | 15.9 | |||||
Common Equity, 5 Yr. CAGR % | 3.97 | -5.31 | -6.83 | -3.79 | -17.73 | |||||
Cash From Operations, 5 Yr. CAGR % | 11.78 | -0.01 | -0.45 | 9.64 | 24.48 | |||||
Capital Expenditures, 5 Yr. CAGR % | -21.79 | -19.81 | -7.18 | -16.86 | -9.79 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 16.67 | 10.21 | 2.18 | 18.79 | 66.39 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 16.71 | 10.7 | 1.71 | 21.7 | 55.74 | |||||
Dividend Per Share, 5 Yr. CAGR % | - | -5.83 | -2.33 | 0.73 | 6.69 |
- Stock Market
- Equities
- TPR Stock
- Financials Tapestry, Inc.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
















